Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial.
Saved in:
| Title: | Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. |
|---|---|
| Authors: | Scheffer IE; University of Melbourne, Austin Health and Royal Children's Hospital, Florey Institute, Melbourne, Victoria, Australia.; Murdoch Children's Research Institutes, Victoria, Australia., Hulihan J; Consultant, Newtown, Pennsylvania., Messenheimer J; Consultant, Moncure, North Carolina., Ali S; Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand., Keenan N; Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand., Griesser J; The Griesser Group, Conshohocken, Pennsylvania., Gutterman DL; Zynerba Pharmaceuticals Inc, Devon, Pennsylvania., Sebree T; Zynerba Pharmaceuticals Inc, Devon, Pennsylvania., Sadleir LG; Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand. |
| Source: | JAMA network open [JAMA Netw Open] 2021 Sep 01; Vol. 4 (9), pp. e2123930. Date of Electronic Publication: 2021 Sep 01. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2021.23930 |
